Venous thromboembolism in patients with lupus nephritis: frequency and risk factors-a cohort study

Autoimmune Disease

Arterial cardiovascular outcomes and venous thromboembolism in patients with primary Sjögren's syndrome: A Danish cohort study

Rheumatology (Oxford)

Loiseau P, Mailhac A, Duhaut P, Thomsen RW

doi: 10.1093/rheumatology/keaf210

Allergic Diseases

Characteristics and Risk Factors of Pollen-Food Allergy Syndrome in Patients With Hay Fever: A Digital Cross-Sectional Cohort Study Using AllerSearch

J Investig Allergol Clin Immunol

Inomata T, Nagino K, Sung J, Midorikawa-Inomata A, Eguchi A, Adachi T, Kobayashi H, Nakao S

doi: 10.18176/jiaci.1101

Further Publications Dermatology

Prognostic factors for patients with cancer-associated dermatomyositis: a retrospective, multicenter cohort study of 73 patients

Rheumatology (Oxford)

Teboul A, Allenbach Y, Tubach F, Belin L, Cassius C, Demortier J, Dossier A, Faucon C, Kasser C, Mekinian A, Monseau G, Fouchard M, Chambrelan E, Viguier M, Kluger N, Mahévas T, Bergeret B, Bachmeyer C, Lenormand C, Hotz C, Diaz E, Cordel N, Benveniste O, Bessis D, Bouaziz JD, Chasset F

doi: 10.1093/rheumatology/keae629

Vitiligo

Evaluating Cancer Risk in a Large Cohort of 25,008 Vitiligo Patients: Insights from a Comprehensive Cohort Population-Based Study

J Am Acad Dermatol

Schonmann Y, Cohen NT, Czarnowicki T

doi: 10.1016/j.jaad.2024.11.043

Rheumatoid Arthritis

New onset work disability in rheumatoid arthritis is an underrecognized cardiovascular risk factor: A retrospective cohort study using the CorEvitas registry

Semin Arthritis Rheum

Spandorfer R, Kane K, Pappas DA, Kremer J, Reed G, Curtis JR, Navarro-Millán I

doi: 10.1016/j.semarthrit.2024.152559

Systemic Lupus Erythematosus

Factors and outcomes related to clinical inertia in systemic lupus erythematosus: a multicentre LUNA cohort study

Rheumatology (Oxford)

Miyake H, Kida T, Yoshimi R, Michizu Y, Nishimura K, Sada KE, Miyawaki Y, Matsuo Y, Ohno S, Kajiyama H, Sato S, Shimojima Y, Fujiwara M, Takatani A, Onishi T, Katsushima M, Ida T, Umekita K, Nakano H, Ikeda K, Ichinose K, Onishi A

doi: 10.1093/rheumatology/keaf504

Atopic Dermatitis

Cardiovascular and thromboembolic risks of JAK inhibitors in atopic dermatitis: A global cohort study

J Eur Acad Dermatol Venereol

Kridin K, Kridin S, Mayer E, Sawaed W, Ludwig RJ

doi: 10.1111/jdv.20864

Systemic Lupus Erythematosus

Kidney outcomes of systemic lupus erythematosus patients treated with SGLT2 inhibitors: A national cohort study

Semin Arthritis Rheum

Sagy I, Shitrit I, Abuhasira R, David RB, Haviv YS, Tayer-Shifman O, Abu-Shakra M, Brav E, Burrack N, Zeller L

doi: 10.1016/j.semarthrit.2025.152746

Rheumatoid Arthritis

Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort study

Lancet Rheumatol

Russell MD, Gibson M, Zuckerman B, Kumar K, Dubey S, Adas MA, Alveyn E, Patel S, Yang Z, Bechman K, Price E, Gallagher S, Cope AP, Norton S, Galloway JB

doi: 10.1016/S2665-9913(24)00221-2

Related content

Arterial cardiovascular outcomes and venous thromboembolism in patients with primary Sjögren's syndrome: A Danish cohort study

Characteristics and Risk Factors of Pollen-Food Allergy Syndrome in Patients With Hay Fever: A Digital Cross-Sectional Cohort Study Using AllerSearch

Prognostic factors for patients with cancer-associated dermatomyositis: a retrospective, multicenter cohort study of 73 patients

Evaluating Cancer Risk in a Large Cohort of 25,008 Vitiligo Patients: Insights from a Comprehensive Cohort Population-Based Study

New onset work disability in rheumatoid arthritis is an underrecognized cardiovascular risk factor: A retrospective cohort study using the CorEvitas registry

Factors and outcomes related to clinical inertia in systemic lupus erythematosus: a multicentre LUNA cohort study

Cardiovascular and thromboembolic risks of JAK inhibitors in atopic dermatitis: A global cohort study

Kidney outcomes of systemic lupus erythematosus patients treated with SGLT2 inhibitors: A national cohort study

Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort study